ClinicalTrials.gg
RecruitingNCT07368062Updated Jul 1, 2026

Mental Health After Dexmedetomidine for Electrical Storm

An observational study in Mental Health, sponsored by Ottawa Heart Institute Research Corporation. Recruiting at 1 site in Canada. Per ClinicalTrials.gov, last updated 2026-07-01.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Ottawa Heart Institute Research Corporation · Observational

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
70
Sex
All
01

Study summary

The goal of the research study is to measure mental health and quality of life indices of individuals treated for electrical storm (ES). The consequences of being admitted to an intensive care unit (ICU) with electrical storm as well as the treatments patients would have received, are currently not well understood. Understanding the mental health burden of these treatments among survivors can provide insights into how to improve care.

This is a study consisting of patients who participated in the SEDATE trial (dexmedetomidine vs usual standard of care to treat ES in the ICU). Patients who consent to participate in this study will be asked to complete a set of questionnaires 3-6 months after their ICU admission. The purpose of the questionnaires is to measure indices of mental health and health-related quality of life. Each questionnaire will take about 5-15 minutes to complete.

If patients have a scheduled follow-up at the University of Ottawa Heart Institute, a member of the research team will meet with them during their clinic visit to complete the questionnaires. Otherwise, they can be completed over the telephone.

02

Conditions studied

  • Mental Health

Browse trials for

Keywords

  • Electrical storm
  • Ventricular tachycardia
  • Dexmedetomidine
  • Mental health
03

In context

Psychological Well-Being Unverified

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

This study's planned enrollment of 70 is below the median of 300 across 361 observational studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Ottawa Heart Institute Research Corporation is the lead sponsor of 182 studies on the registry; 42 are open to participants now.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients previously admitted at the University of Ottawa Heart Institute's Intensive Cardiac Care Unit with electrical storm and enrolled in the SEDATE trial at that time will be contacted to obtain consent for study participation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients admitted to an intensive care unit with a diagnosis of electrical storm within the preceding 6 months
  • Previous participants in the SEDATE trial (NCT06281977)

Exclusion criteria

Exclusion Criteria:

- None

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Dexmedetomidine

    Treatment with dexmedetomidine during electrical storm admission

    Drug: Dexmedetomidine

  • Placebo

    Usual standard of care (not including dexmedetomidine) during electrical storm admission

    Drug: Placebo

Interventions

  • Dexmedetomidine infusion during ICU admission for electrical storm

  • DrugPlacebo

    Placebo (standard of care, no dexmedetomidine), for treatment of electrical storm while admitted to ICU

06

What researchers measure

Primary outcomes

  1. Post-traumatic stress disorder symptoms

    Post-traumatic stress disorder (PTSD) checklist (PCL-5) score. Respondents are asked to rate the presence and severity of various symptoms in the preceding month on 5-point Likert scale. A higher score indicates worse symptoms. A cumulative cut-off score of 31-33 is usually considered indicative of probable PTSD

    Time frame: Assessed 3-6 months after hospitalization for electrical storm

Secondary outcomes

  1. Anxiety symptoms

    General Anxiety Disorder 7-item (GAD-7). This is a screening tool for the presence and measure of the severity of anxiety symptoms. A higher score suggests more severe symptoms

    Time frame: Assessed 3-6 months after hospitalization for electrical storm

  2. Depression symptoms

    Patient Health Questionnaire-9 (PHQ-9). This is a screening tool for the presence and measure of the severity of depression symptoms. A higher score suggests more severe symptoms.

    Time frame: Assessed 3-6 months after hospitalization for electrical storm

  3. Anxiety/fear relating to implantable cardioverter-defibrillator shocks

    Florida Shock Anxiety Scale (FSAS). This is a measure of patient anxiety/fear relating to implantable cardioverter-defibrillator shocks. A higher score suggests more shock-related anxiety

    Time frame: Assessed 3-6 months after hospitalization for electrical storm

  4. Quality of life measure

    Quality of life measurements, as obtained through use of the 36-Item Short Form Survey Instrument (SF-36), a validated questionnaire tool to measure health-related quality of life/health status across specific domains. A higher score indicates better self-reported health

    Time frame: Assessed 3-6 months after hospitalization for electrical storm

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Dec 2027, 33 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2025
First posted
Jan 26, 2026
StartActual
Mar 15, 2025
Primary completionEst.
Dec 2027
CompletionEst.
Jun 2028
Last update
Jul 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07368062
Responsible party
Sponsor
First posted
Jan 26, 2026
Start date
Mar 15, 2025
Primary completion
Dec 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Jul 1, 2026

Study contacts

F Daniel Ramirez, MD MSc FRCPC
Contact
dramirez@ottawaheart.ca
1+ 613-696-7000

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion